What are the latest funding news in the healthcare AI market? (May 2026)
Download our beautiful pitch about the healthcare AI market

In our healthcare AI market deck, you will find everything you need to understand the market
Healthcare AI funding stayed very active in spring 2026, with large rounds for clinical AI, medical imaging, revenue cycle automation, and AI infrastructure for health systems.
The biggest checks went to companies that are already selling into hospitals, payers, and life sciences teams, which shows that investors are prioritizing healthcare AI products with clear buyers.
From March 24 to April 30, 2026, we found 12 relevant healthcare AI funding deals, including Aidoc, Qualified Health, Iterative Health, Thesis Care, and Adonis.
And if you want to better understand this new industry, you can download our pitch covering the healthcare AI market.
Insights
- Healthcare AI funding was not just about diagnostics: only one of the 12 deals was mainly imaging, while workflow, payer, and clinical operations platforms made up most activity.
- The top two disclosed rounds, Aidoc and Qualified Health, reached $275M combined, showing strong investor appetite for enterprise-grade AI adoption inside health systems.
- Revenue cycle and payer operations were a clear funding theme, with Adonis, Keebler Health, Yuzu Health, and Luminai together raising $129M.
- Clinical workflow AI remained broad, covering EHR guidance, voice agents, care teams, and virtual consultations rather than one single product category.
- Late-stage healthcare AI companies still attracted the largest rounds, but seed and Series A companies also raised meaningful checks when the use case was specific.
- AI for clinical research was a major highlight, with Iterative Health raising $77M for AI-enabled trial recruitment and site operations.
- Behavioral health AI continued to mature, with Jimini Health positioning its platform around clinician-supervised support rather than unsupervised consumer chatbot use.
- General Catalyst appeared in several deals, which suggests continued conviction in healthcare AI infrastructure, workflow automation, and payer operations.

As this chart shows, and as featured in our healthcare AI market deck, search interest in healthcare AI has grown rapidly
Summary table of the latest funding deals in the healthcare AI market as of May 2026
We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.
We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.
We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.
You can also read our detailed analysis to understand how funding activity in the healthcare AI market has evolved over the last few years.
We also have a quarter-by-quarter analysis of funding activity in the market here.
Finally, you can check our complete list of fundraising deals for the healthcare AI market (we update this list every quarter) as well as our ranking of the most funded startups.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| Doctronic | Mar 24, 2026 | $40M | Series B | Virtual care & clinical decision support |
| Thesis Care | Mar 25, 2026 | $45M | Series A | Clinical operations & care management AI |
| Qualified Health | Mar 25, 2026 | $125M | Series B | Provider AI governance & deployment infrastructure |
| Adonis | Mar 25, 2026 | $40M | Series C | Revenue cycle management AI |
| Avo | Mar 31, 2026 | $10M | Series A | Clinical decision support & provider workflow AI |
| Jimini Health | Apr 2, 2026 | $17M | Seed | Behavioral health AI & clinical monitoring |
| Insight Health | Apr 3, 2026 | $11M | Series A | Clinic workflow automation & voice AI agents |
| Yuzu Health | Apr 6, 2026 | $35M | Series A | Payer infrastructure & claims automation |
| Luminai | Apr 9, 2026 | $38M | Series B | Healthcare operations & revenue cycle automation |
| Keebler Health | Apr 15, 2026 | $16M | Series A | Risk adjustment & payer analytics AI |
| Aidoc | Apr 29, 2026 | $150M | Series E | Medical imaging AI & clinical workflow |
| Iterative Health | Apr 30, 2026 | $77M | Series C | Clinical trials AI & life sciences operations |
All the latest funding deals during in the healthcare AI market as of May 2026
Iterative Health raised $77M in April 2026
When was it?
The deal was announced on April 30, 2026.
Who are they?
Iterative Health runs an AI-enabled clinical research network for GI, hepatology, obesity, and cardiology trials.
Geographical focus?
Iterative Health focuses mainly on the United States, with a model built around research sites, sponsors, and CROs.
Why do we include them in the healthcare AI market?
Iterative Health fits the healthcare AI market because the platform uses AI tools to improve clinical trial enrollment and execution for life sciences customers.
What is the company stage?
Iterative Health is at growth stage, with a clinical research network and institutional investors backing expansion.
How much did they raise?
Iterative Health raised $77M for this round.
What round is it?
The round was a Series C.
Why did they raise?
Iterative Health raised to accelerate clinical research operations and expand its site network.
Aidoc raised $150M in April 2026
When was it?
The deal was announced on April 29, 2026.
Who are they?
Aidoc provides a clinical AI imaging platform that helps care teams detect, triage, and coordinate urgent findings.
Geographical focus?
Aidoc has a global focus, with hospital and health system customers across multiple markets.
Why do we include them in the healthcare AI market?
Aidoc fits the healthcare AI market because the company sells diagnostic and clinical workflow AI to radiology, cardiology, vascular, and neurovascular teams.
What is the company stage?
Aidoc is at late growth stage, with a large installed base and a major new Series E round.
How much did they raise?
Aidoc raised $150M for this round.
What round is it?
The round was a Series E.
Why did they raise?
Aidoc raised to expand its CARE clinical-grade foundation model, grow globally, and add more clinical indications.

This chart, featured in our healthcare AI market deck, compares the main business model options for ambient AI companies
Keebler Health raised $16M in April 2026
When was it?
The deal was announced on April 15, 2026.
Who are they?
Keebler Health offers an LLM-native platform that reads clinical documentation for risk adjustment and population health teams.
Geographical focus?
Keebler Health focuses on the United States, especially value-based care organizations and healthcare payers.
Why do we include them in the healthcare AI market?
Keebler Health fits the healthcare AI market because the product supports payer analytics, risk adjustment, claims quality, and provider workflow use cases.
What is the company stage?
Keebler Health is at early growth stage, with a Series A round and a focused healthcare data product.
How much did they raise?
Keebler Health raised $16M for this round.
What round is it?
The round was a Series A.
Why did they raise?
Keebler Health raised to grow commercially, expand the team, and support value-based care organizations nationwide.
Luminai raised $38M in April 2026
When was it?
The deal was announced on April 9, 2026.
Who are they?
Luminai provides an AI automation platform for healthcare operations such as referrals, prior authorization, claims, and eligibility.
Geographical focus?
Luminai focuses on the United States, with health system operations and partners such as Cleveland Clinic.
Why do we include them in the healthcare AI market?
Luminai fits the healthcare AI market because the product automates hospital and clinic workflows, including revenue cycle and administrative operations.
What is the company stage?
Luminai is at growth stage, with a Series B round and expansion across health system operations.
How much did they raise?
Luminai raised $38M for this round.
What round is it?
The round was a Series B.
Why did they raise?
Luminai raised to scale automation across healthcare operations and deepen work with health systems.

This chart, featured in our healthcare AI market deck, looks at Tempus AI’s strategy in healthcare AI
Yuzu Health raised $35M in April 2026
When was it?
The deal was announced on April 6, 2026.
Who are they?
Yuzu Health builds modern TPA infrastructure for health insurance plans, including claims, payments, and member administration.
Geographical focus?
Yuzu Health focuses on the United States health insurance market.
Why do we include them in the healthcare AI market?
Yuzu Health fits the healthcare AI market because the company automates payer infrastructure, claims workflows, and health plan administration.
What is the company stage?
Yuzu Health is moving from product-market fit to early growth, with a Series A round and commercial traction.
How much did they raise?
Yuzu Health raised $35M for this round.
What round is it?
The round was a Series A.
Why did they raise?
Yuzu Health raised to automate plan administration workflows and modernize health insurance infrastructure.
Insight Health raised $11M in April 2026
When was it?
The deal was announced on April 3, 2026.
Who are they?
Insight Health builds voice-first clinical AI agents that reduce administrative work for healthcare clinics.
Geographical focus?
Insight Health focuses on clinics in the United States.
Why do we include them in the healthcare AI market?
Insight Health fits the healthcare AI market because the company sells clinic workflow automation and clinical operations AI.
What is the company stage?
Insight Health is at early product-market fit stage, with a Series A round and a focused clinic automation product.
How much did they raise?
Insight Health raised $11M for this round.
What round is it?
The round was a Series A.
Why did they raise?
Insight Health raised to reduce administrative bottlenecks and scale clinical AI agents across U.S. clinics.

In our healthcare AI market deck, we identify pain points entrepreneurs should prioritize
Jimini Health raised $17M in April 2026
When was it?
The deal was announced on April 2, 2026.
Who are they?
Jimini Health offers a clinician-supervised behavioral health AI platform for support between therapy sessions.
Geographical focus?
Jimini Health focuses on the United States behavioral health market.
Why do we include them in the healthcare AI market?
Jimini Health fits the healthcare AI market because the product supports clinical monitoring and behavioral health care delivery under clinician supervision.
What is the company stage?
Jimini Health is at early product-market fit stage, with seed funding and a defined clinical use case.
How much did they raise?
Jimini Health raised $17M for this round.
What round is it?
The round was a seed round.
Why did they raise?
Jimini Health raised to build safe AI infrastructure for behavioral health providers.
Avo raised $10M in March 2026
When was it?
The deal was announced on March 31, 2026.
Who are they?
Avo provides an EHR-integrated clinical AI platform that turns trusted medical knowledge and patient data into clinician guidance.
Geographical focus?
Avo focuses mainly on the United States provider market.
Why do we include them in the healthcare AI market?
Avo fits the healthcare AI market because the company sells clinical decision support and provider workflow AI inside the EHR.
What is the company stage?
Avo is at product-market fit stage, with a Series A round and a focused EHR-native product.
How much did they raise?
Avo raised $10M for this round.
What round is it?
The round was a Series A.
Why did they raise?
Avo raised to expand its EHR-native clinical intelligence platform and go-to-market activity.

This market map, featured in our healthcare AI market deck, highlights top companies and startups in the healthcare AI market
Adonis raised $40M in March 2026
When was it?
The deal was announced on March 25, 2026.
Who are they?
Adonis provides an AI orchestration platform for healthcare billing, denials, collections, and revenue cycle operations.
Geographical focus?
Adonis focuses on the United States healthcare provider market.
Why do we include them in the healthcare AI market?
Adonis fits the healthcare AI market because the product automates provider revenue cycle management with AI.
What is the company stage?
Adonis is at growth stage, with a Series C round and a clear healthcare operations focus.
How much did they raise?
Adonis raised $40M for this round.
What round is it?
The round was a Series C.
Why did they raise?
Adonis raised to deepen AI-driven payment operations for provider groups and health systems.
Qualified Health raised $125M in March 2026
When was it?
The deal was announced on March 25, 2026.
Who are they?
Qualified Health offers an enterprise AI platform that helps health systems evaluate, govern, and deploy AI safely.
Geographical focus?
Qualified Health focuses on United States health systems and enterprise healthcare organizations.
Why do we include them in the healthcare AI market?
Qualified Health fits the healthcare AI market because the platform helps providers govern and deploy AI across clinical and administrative workflows.
What is the company stage?
Qualified Health is at growth stage, with a large Series B round and strong institutional investor support.
How much did they raise?
Qualified Health raised $125M for this round.
What round is it?
The round was a Series B.
Why did they raise?
Qualified Health raised to meet demand from health systems scaling AI safely across clinical and administrative workflows.

This chart, featured in our healthcare AI market deck, shows annual funding in healthcare AI startups
Thesis Care raised $45M in March 2026
When was it?
The deal was announced on March 25, 2026.
Who are they?
Thesis Care combines AI agents with expert clinicians to build scalable clinical operations and care teams.
Geographical focus?
Thesis Care focuses mainly on the United States healthcare market.
Why do we include them in the healthcare AI market?
Thesis Care fits the healthcare AI market because the company uses AI for clinical operations, care management, and provider workflow support.
What is the company stage?
Thesis Care is moving from product-market fit to growth, with a Series A round and commercial partnerships.
How much did they raise?
Thesis Care raised $45M for this round.
What round is it?
The round was a Series A.
Why did they raise?
Thesis Care raised to scale AI-powered clinical teams and expand commercial partnerships.
Doctronic raised $40M in March 2026
When was it?
The deal was announced on March 24, 2026.
Who are they?
Doctronic offers an AI doctor platform for HIPAA-compliant consultations, telehealth, diagnosis, prescriptions, and care navigation.
Geographical focus?
Doctronic focuses on the United States virtual care market.
Why do we include them in the healthcare AI market?
Doctronic fits the healthcare AI market because the company offers virtual care and clinical decision-support AI for patients and care delivery partners.
What is the company stage?
Doctronic is moving from product-market fit to growth, with a Series B round and expanding clinical services.
How much did they raise?
Doctronic raised $40M for this round.
What round is it?
The round was a Series B.
Why did they raise?
Doctronic raised to expand partnerships, pediatrics, and prescription services.
Related blog posts
- How strong is fundraising in the healthcare AI market right now?
- What is the latest news in healthcare AI?
- What is the real size of the healthcare AI market?
- How funding activity has changed in healthcare AI
- What are the latest fundraising trends in healthcare AI?
- All the funding deals in healthcare AI
- Which startups have raised the most funding in the healthcare AI market?
- Which startups are the most valued in the healthcare AI market?
- A complete list of business models in the healthcare AI market
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.
How we created this content 🔎📝
At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.
So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.
Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.